126068-76-6 Usage
Description
1-(4-Methoxy-phenyl)-5-methyl-1H-pyrazole-3-carboxylic acid ethyl ester is a chemical compound belonging to the pyrazole class, featuring a carboxylic acid and an ethyl ester group. This derivative is distinguished by its methyl and methoxy substitution on the phenyl ring, which contributes to its unique properties and potential applications in the fields of chemistry and drug development.
Uses
Used in Pharmaceutical Applications:
1-(4-Methoxy-phenyl)-5-methyl-1H-pyrazole-3-carboxylic acid ethyl ester is used as a precursor or intermediate for the synthesis of various bioactive compounds and pharmaceutical drugs. Its specific properties and potential uses may vary depending on the context and application within the field of chemistry and drug development.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, 1-(4-Methoxy-phenyl)-5-methyl-1H-pyrazole-3-carboxylic acid ethyl ester is utilized as a key component in the development of novel therapeutic agents. Its structural features allow for the creation of new molecules with potential medicinal properties, targeting a range of health conditions and diseases.
Check Digit Verification of cas no
The CAS Registry Mumber 126068-76-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,6,0,6 and 8 respectively; the second part has 2 digits, 7 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 126068-76:
(8*1)+(7*2)+(6*6)+(5*0)+(4*6)+(3*8)+(2*7)+(1*6)=126
126 % 10 = 6
So 126068-76-6 is a valid CAS Registry Number.
InChI:InChI=1/C14H16N2O3/c1-4-19-14(17)13-9-10(2)16(15-13)11-5-7-12(18-3)8-6-11/h5-9H,4H2,1-3H3
126068-76-6Relevant articles and documents
Design and Synthesis of Imidazole and Triazole Pyrazoles as Mycobacterium Tuberculosis CYP121A1 Inhibitors
Kishk, Safaa M.,McLean, Kirsty J.,Sood, Sakshi,Smith, Darren,Evans, Jack W.D.,Helal, Mohamed A.,Gomaa, Mohamed S.,Salama, Ismail,Mostafa, Samia M.,de Carvalho, Luiz Pedro S.,Levy, Colin W.,Munro, Andrew W.,Simons, Claire
, p. 995 - 1011 (2019)
The emergence of untreatable drug-resistant strains of Mycobacterium tuberculosis is a major public health problem worldwide, and the identification of new efficient treatments is urgently needed. Mycobacterium tuberculosis cytochrome P450 CYP121A1 is a p
Optimization of non-ATP competitive CDK/cyclin groove inhibitors through REPLACE-mediated fragment assembly
Liu, Shu,Premnath, Padmavathy Nandha,Bolger, Joshua K.,Perkins, Tracy L.,Kirkland, Lindsay O.,Kontopidis, George,McInnes, Campbell
, p. 1573 - 1582 (2013/04/10)
A major challenge in drug discovery is to develop and improve methods for targeting protein-protein interactions. Further exemplification of the REPLACE (REplacement with Partial Ligand Alternatives through Computational Enrichment) strategy for generatin
